198 related articles for article (PubMed ID: 31181422)
1. Decreased number of CD19
Li T; Yu Z; Qu Z; Zhang N; Crew R; Jiang Y
Mol Immunol; 2019 Aug; 112():233-239. PubMed ID: 31181422
[TBL] [Abstract][Full Text] [Related]
2. Reduced CD5(+) CD24(hi) CD38(hi) and interleukin-10(+) regulatory B cells in active anti-neutrophil cytoplasmic autoantibody-associated vasculitis permit increased circulating autoantibodies.
Aybar LT; McGregor JG; Hogan SL; Hu Y; Mendoza CE; Brant EJ; Poulton CJ; Henderson CD; Falk RJ; Bunch DO
Clin Exp Immunol; 2015 May; 180(2):178-88. PubMed ID: 25376552
[TBL] [Abstract][Full Text] [Related]
3. Decrease in the proportion of CD24
Wang Y; Qin Y; Wang X; Zhang L; Wang J; Xu X; Chen H; Hsu HT; Zhang M
Clin Exp Immunol; 2020 Apr; 200(1):22-32. PubMed ID: 31849037
[TBL] [Abstract][Full Text] [Related]
4. CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation.
Flores-Borja F; Bosma A; Ng D; Reddy V; Ehrenstein MR; Isenberg DA; Mauri C
Sci Transl Med; 2013 Feb; 5(173):173ra23. PubMed ID: 23427243
[TBL] [Abstract][Full Text] [Related]
5. CD19
Chen Q; Lai L; Chi X; Lu X; Wu H; Sun J; Wu W; Cai L; Zeng X; Wang C; Chen W; Peng A
Mediators Inflamm; 2020; 2020():3019378. PubMed ID: 32104147
[TBL] [Abstract][Full Text] [Related]
6. Chronic obstructive pulmonary disease is characterized by reduced levels and defective suppressive function of regulatory B cells in peripheral blood.
Lin S; Ma Z; Huang Y; Sun Y; Yi H
Mol Immunol; 2022 Jan; 141():87-93. PubMed ID: 34837778
[TBL] [Abstract][Full Text] [Related]
7. Elevated circulating CD19
Deng B; Deng L; Liu M; Zhao Z; Huang H; Tu X; Liang E; Tian R; Wang X; Wang R; Lin H; Yu Y; Peng A; Xu P; Bao K; He M
Immunol Lett; 2023 Sep; 261():58-65. PubMed ID: 37553031
[TBL] [Abstract][Full Text] [Related]
8. The correlation of CD19 + CD24 + CD38 + B cells and other clinicopathological variables with the proportion of circulating Tregs in breast cancer patients.
Gheybi MK; Farrokhi S; Ravanbod MR; Ostovar A; Mehrzad V; Nematollahi P
Breast Cancer; 2017 Nov; 24(6):756-764. PubMed ID: 28429331
[TBL] [Abstract][Full Text] [Related]
9. Deficit of circulating CD19
Zaimoku Y; Patel BA; Kajigaya S; Feng X; Alemu L; Quinones Raffo D; Groarke EM; Young NS
Br J Haematol; 2020 Aug; 190(4):610-617. PubMed ID: 32311088
[TBL] [Abstract][Full Text] [Related]
10. PD-L1
Zacca ER; Onofrio LI; Acosta CDV; Ferrero PV; Alonso SM; Ramello MC; Mussano E; Onetti L; Cadile II; Stancich MI; Taboada Bonfanti MC; Montes CL; Acosta Rodríguez EV; Gruppi A
Front Immunol; 2018; 9():2241. PubMed ID: 30327652
[No Abstract] [Full Text] [Related]
11. CD24
Hasan MM; Thompson-Snipes L; Klintmalm G; Demetris AJ; O'Leary J; Oh S; Joo H
J Immunol; 2019 Oct; 203(8):2110-2120. PubMed ID: 31511354
[TBL] [Abstract][Full Text] [Related]
12. BREG cells in Hashimoto's thyroiditis isolated or associated to further organ-specific autoimmune diseases.
Santaguida MG; Gatto I; Mangino G; Virili C; Stramazzo I; Fallahi P; Antonelli A; Segni M; Romeo G; Centanni M
Clin Immunol; 2017 Nov; 184():42-47. PubMed ID: 28461108
[TBL] [Abstract][Full Text] [Related]
13. Impact of deranged B cell subsets distribution in the development of HCV-related cirrhosis and HCC in type two diabetes mellitus.
Abdelwahab FA; Hassanein KM; Hetta HF; Abdelmalek MO; Zahran AM; El-Badawy O
Sci Rep; 2020 Nov; 10(1):20383. PubMed ID: 33230233
[TBL] [Abstract][Full Text] [Related]
14. Regulatory B cells (CD19(+)CD38(hi)CD24(hi)) in alloimmunized and non-alloimmunized children with β-thalassemia major.
Zahran AM; Elsayh KI; Saad K; Embaby M; Ali AM
Blood Cells Mol Dis; 2016 Mar; 57():91-6. PubMed ID: 26852663
[TBL] [Abstract][Full Text] [Related]
15. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients.
Blair PA; Noreña LY; Flores-Borja F; Rawlings DJ; Isenberg DA; Ehrenstein MR; Mauri C
Immunity; 2010 Jan; 32(1):129-40. PubMed ID: 20079667
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-35 promotes Breg expansion and interleukin-10 production in CD19
Zhang Y; Wei S; Wu Q; Shen X; Dai W; Zhang Z; Chen M; Huang H; Ma L
Clin Rheumatol; 2022 Aug; 41(8):2403-2416. PubMed ID: 35420296
[TBL] [Abstract][Full Text] [Related]
17. CD24
Xu C; Zhang M; Li K; Ni M; Bai Y; Zhang J; Song X; Wang J
Int Immunopharmacol; 2019 May; 70():295-301. PubMed ID: 30851710
[TBL] [Abstract][Full Text] [Related]
18. B cell subsets and dysfunction of regulatory B cells in IgG4-related diseases and primary Sjögren's syndrome: the similarities and differences.
Lin W; Jin L; Chen H; Wu Q; Fei Y; Zheng W; Wang Q; Li P; Li Y; Zhang W; Zhao Y; Zeng X; Zhang F
Arthritis Res Ther; 2014 May; 16(3):R118. PubMed ID: 24887143
[TBL] [Abstract][Full Text] [Related]
19. A Lower Proportion of Regulatory B Cells in Patients with Henoch-Schoenlein Purpura Nephritis.
Hu X; Tai J; Qu Z; Zhao S; Zhang L; Li M; Sun X; Jiang Y
PLoS One; 2016; 11(3):e0152368. PubMed ID: 27030970
[TBL] [Abstract][Full Text] [Related]
20. Characterization of CD19
Gu Y; Li K; Sun J; Zhang J
J Eur Acad Dermatol Venereol; 2020 Dec; 34(12):2863-2870. PubMed ID: 32242984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
